Old Web
English
Sign In
Acemap
>
Paper
>
Biosimilar Infliximab: Feedback After A Nine Months Experience Of Their Use In The 37 Public Hospitals Of Paris
Biosimilar Infliximab: Feedback After A Nine Months Experience Of Their Use In The 37 Public Hospitals Of Paris
2016
François Bocquet
A. Degrassat-Théas
A. Cordonnier
C. Raybaut
O. Parent de Curzon
I Fusier
Pascal Paubel
Keywords:
Biosimilar
Intensive care medicine
Infliximab
Medicine
Alternative medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]